Calcium antagonists and the kidney: future therapeutic perspectives.
During the past decade, attention has focused on the effects of calcium antagonists on renal function. Recent studies using diverse videomicroscopic techniques including the isolated perfused hydronephrotic rat kidney model, which permits direct visualization of afferent and efferent arterioles, have demonstrated that calcium antagonists acutely antagonize preglomerular vasoconstriction. In contrast, most studies suggest that the efferent arteriole appears to be refractory to the vasodilatory effects of these agents. Although the clinical implications of such observations have not been fully delineated, the results of recent studies indicate that calcium antagonists exert salutary effects on renal function in clinical settings characterized by impaired renal hemodynamics, including transplant-associated acute renal insufficiency and, possibly, cyclosporine nephrotoxicity. Evidence has accrued to suggest that calcium antagonists also may be protective against acute radiocontrast-induced nephrotoxicity. Finally, the renal hemodynamic and natriuretic effects of calcium antagonists commend their use as antihypertensive agents in the management of essential hypertension and transplant-associated hypertension.
Epstein
M
M
Nephrology Section, Veterans Affairs Medical Center, Miami, FL 33125.
D058186:Acute Kidney Injury / Q000139:chemically induced / Q000517:prevention & control*; D000666:Amphotericin B / Q000009:adverse effects; D000818:Animals; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D003287:Contrast Media / Q000009:adverse effects; D003925:Diabetic Angiopathies / Q000188:drug therapy*; D005544:Forecasting; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007676:Kidney Failure, Chronic / Q000517:prevention & control; D016030:Kidney Transplantation / Q000009:adverse effects
D002121:Calcium Channel Blockers; D003287:Contrast Media; D000666:Amphotericin B